Atmo Biosciences announces publication of pivotal clinical study results supporting initial indication
Posted: 6 March 2025 Today, Atmo Biosciences announced the publication of pivotal clinical study data in Clinical Gastroenterology and Hepatology. The study validates the Atmo Capsule for assessing whole and regional gastrointestinal transit times to assist with the…
BioMelbourne Network announces new Board Chair appointment
Posted: 6 March 2025 BioMelbourne Network, the peak industry body for the life sciences sector in Victoria, announces that its Chair, David Herd, will retire from the Board on 28 April 2025. The Board has elected Dr Emma…
2025 BioSymposium Agenda: Innovations in technologies – Implantables, Neurotech and Diagnostics
Tuesday 25 March 2025 | 8:30 AM – 6:00 PM AEDT 08:30 AM Guest arrival and registration
Institute appoints Deputy Directors to lead with heart
Posted: 4 March 2025 The Victorian Heart Institute (VHI) has announced the appointment of three Deputy Directors to support the Institute’s leadership as it continues to drive innovation in cardiovascular research, education, prevention and care. Professor Francine Marques (Deputy…
Bold vision to transform the health and wellbeing of children in Australia
Posted: 4 March 2025 Two of the largest studies of their kind in Australia have a bold vision to come together to transform the health and wellbeing of children now and for future generations. GenV, tracking the health…
BioForum Insights: Prof Andrew Wilks and Amanda Handley on bringing medicines to market
Posted: 28 February 2025 What does it take to translate groundbreaking research into commercial success, and how do we cultivate more success stories? That was the central question of our first BioForum of 2025 that brought together around…
Regional Lung Volume Changes with Non-Invasive Positive Pressure Ventilation in Healthy Adults
Posted: 26 February 2025 This study highlights the potential of using XV, an advanced functional imaging tool, to better understand regional lung function and optimize the therapeutic application of Non-Invasive Positive Pressure Ventilation (NIPPV). These insights could pave…
Innovative dual-target drug may lead to new investigational approach for breast cancer patients
Posted: 26 February 2025 Researchers discover new insights into how dual-target drug may supercharge cancer-fighting immune cells. Researchers, led by the University of Melbourne’s Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute…
Doherty Institute researchers receive over $30.5 million in NHMRC funding for critical health research
Posted: 26 February 2025 Fourteen researchers at the Doherty Institute have secured over $30.5 million from the National Health and Medical Research Council (NHMRC) Investigator Grant Scheme to tackle major health challenges with projects addressing antimicrobial resistance, influenza,…
Australia-Japan collaboration secures $4.3m for cutting-edge HTLV treatment research
Posted: 26 February 2025 Global research on Human T-cell lymphotropic virus (HTLV), classified by the WHO as a Threatening Pathogen to Humans, has received a significant funding boost from Australia’s National Health and Medical Research Council (NHMRC) and…
INFORMATION about Stephens Lawyers & Consultants’ Complimentary IP Audit Questionnaire – now available
Posted: 25 February 2025 Intellectual Property Audit and Review Questionnaire – When did your business last do an IP audit? Perhaps your business is about to embark on a major advertising campaign, has developed new product branding or…
